• Flexible Solutions appointed Dr. Kim Reid to its board as a director and audit committee member.
• Reid is a process development scientist and postdoctoral fellow at the Ottawa Hospital Research Institute, leading mRNA-LNP cancer-vaccine GMP scale-up.
• Director John Bientjes resigned from the board, ending nearly 30 years of service.
• Audit committee chair shifted to David Fynn, a long-serving audit committee member.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Flexible Solutions International Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608311630PRIMZONEFULLFEED9818845) on August 31, 2026, and is solely responsible for the information contained therein.